BaltCap, the Baltic-focused private equity firm, has sold Medicap Holding to synlab, a European provider of laboratory services. synlab has acquired 100 per cent of Medicap Holding, which owns Estonian, Finnish and Lithuanian laboratories operating under the Quattromed and Sorpo brand names, from BaltCap and individual shareholders. By
Kohlberg Kravis Roberts has completed its acquisition of all of the outstanding shares of Gardner Denver for approximately USD3.9bn, including the assumption of debt. Timothy W Sullivan has been appointed as president and chief executive officer of Gardner Denver, effective immediately. Michael M Larsen has transitioned to the role of
Funds affiliated with Apollo Global Management have signed a definitive agreement under which Apollo will acquire Pitney Bowes Management Services (PBMS) for approximately USD400m in cash. The transaction, which is subject to customary closing conditions, is expected to close in the fourth quarter of 2013. Until then, Pitney Bowes
L’ArcoBaleno has secured a seven-figure financing round from a group of international investors. L’ArcoBaleno is positioned to lead the luxury design industry by bringing a curated marketplace of intriguing and valuable furniture, lighting, crafts and decorative arts direct to consumers. Since its launch in June, consumers around the
Activa Capital and Bpifrance have signed agreements with the managers of Nexeya and several financial shareholders relating to the acquisition of a majority block representing 57.9 per cent of total capital and 58.7 per cent of voting rights for EUR12.00 per share. Nexeya is an industrial group which operates mainly
RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, has completed the acquisition of Santa Cruz Nutritionals (SCN) from Levine Leichtman Capital Partners. SCN, founded in 1968, is a manufacturer of gummy vitamin, mineral, supplement (VMS) and other nutraceutical products in the US. Financial terms
SigmaCare has secured new equity funding from healthcare investment firm Marlin Equity Partners and existing investors. SigmaCare provides clinical software to the long-term and post-acute care market enabling providers to improve quality of care and financial results by driving down costs, increasing revenue and reducing risk and re-hospitalisations.
Green Innovations has settled over USD2.6m in trade payables, removing these obligations from its balance sheet, in exchange for the issuance of shares of its common stock to Ironridge Consumer Co, an institutional investor specialising in direct equity investments in consumer product companies. As a result of the transaction,
Venture capital fund manager Mercia Fund Management (MFM) has invested GBP150,000 in Oxford Genetics Ltd. The new biotechnology company is behind SnapFast – a system that simplifies the purchase of synthetic DNA molecules (plasmids). Dr Ryan Cawood, chief executive of Oxford Genetics, invented the SnapFast system and likens
A fifth portfolio company of life sciences venture capital firm Domain Associates has received funding under its investment agreement with Russian state investment corporation Rusnano. ReVision Optics, a Southern California-based firm developing Raindrop, an inlay for presbyopic vision correction in Phase III trials, has raised USD55m in a financing
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
